Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

04/08/2023 07:00

Aug 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.86                2.02                      
                 (-8.1 pct)          (+2.9 pct)                   
  Operating      loss 57 mln         loss 24 mln                  
  Recurring      loss 28 mln         loss 2 mln                   
  Net              100 mln           loss 4 mln                   
  EPS             2.90 yen          loss 0.14 yen                 
  Ann Div                             3.00 yen                    
  -Q2 div                                NIL                      
  -Q4 div                             3.00 yen                    
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T